- Home
- WDS vs BNTX Comparison
WDS vs BNTX Comparison
Compare WDS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDS
- BNTX
- Stock Information
- Founded
- WDS 1954
- BNTX 2008
- Country
- WDS Australia
- BNTX Germany
- Employees
- WDS N/A
- BNTX N/A
- Industry
- WDS Oil & Gas Production
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WDS Energy
- BNTX Health Care
- Exchange
- WDS Nasdaq
- BNTX Nasdaq
- Market Cap
- WDS 23.9B
- BNTX 26.4B
- IPO Year
- WDS N/A
- BNTX 2019
- Fundamental
- Price
- WDS $15.76
- BNTX $110.02
- Analyst Decision
- WDS Hold
- BNTX Strong Buy
- Analyst Count
- WDS 2
- BNTX 18
- Target Price
- WDS N/A
- BNTX $140.27
- AVG Volume (30 Days)
- WDS 700.2K
- BNTX 575.8K
- Earning Date
- WDS 08-26-2025
- BNTX 08-04-2025
- Dividend Yield
- WDS 7.46%
- BNTX N/A
- EPS Growth
- WDS 115.08
- BNTX N/A
- EPS
- WDS 1.87
- BNTX N/A
- Revenue
- WDS $13,179,000,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- WDS N/A
- BNTX N/A
- Revenue Next Year
- WDS N/A
- BNTX $8.61
- P/E Ratio
- WDS $8.46
- BNTX N/A
- Revenue Growth
- WDS N/A
- BNTX 0.61
- 52 Week Low
- WDS $11.26
- BNTX $76.53
- 52 Week High
- WDS $20.06
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- WDS 54.16
- BNTX 53.75
- Support Level
- WDS $15.52
- BNTX $108.72
- Resistance Level
- WDS $15.94
- BNTX $112.58
- Average True Range (ATR)
- WDS 0.25
- BNTX 2.62
- MACD
- WDS -0.06
- BNTX -0.12
- Stochastic Oscillator
- WDS 61.07
- BNTX 54.01
About WDS Woodside Energy Group Limited
Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2010, Shell further decreased its shareholding to 24%. Woodside has the potential to become the most LNG-leveraged company globally.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.